CARRECA, Ignazio
 Distribuzione geografica
Continente #
NA - Nord America 3.232
EU - Europa 1.925
AS - Asia 1.528
SA - Sud America 221
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 29
OC - Oceania 3
Totale 7.013
Nazione #
US - Stati Uniti d'America 3.175
SG - Singapore 526
CN - Cina 429
RU - Federazione Russa 400
IT - Italia 336
DE - Germania 291
UA - Ucraina 229
BR - Brasile 160
HK - Hong Kong 148
FI - Finlandia 134
PL - Polonia 124
VN - Vietnam 119
GB - Regno Unito 93
FR - Francia 90
IE - Irlanda 74
JP - Giappone 70
KR - Corea 53
SE - Svezia 52
IN - India 39
RO - Romania 23
BD - Bangladesh 22
TR - Turchia 20
CA - Canada 19
NL - Olanda 19
CO - Colombia 18
MX - Messico 17
IQ - Iraq 16
BE - Belgio 14
TH - Thailandia 12
ES - Italia 11
VE - Venezuela 11
AR - Argentina 10
EC - Ecuador 10
AT - Austria 9
MY - Malesia 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CH - Svizzera 6
ID - Indonesia 6
PH - Filippine 6
UZ - Uzbekistan 6
AM - Armenia 5
CR - Costa Rica 5
JO - Giordania 5
PK - Pakistan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GR - Grecia 4
IR - Iran 4
TN - Tunisia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
KE - Kenya 3
LU - Lussemburgo 3
MA - Marocco 3
NI - Nicaragua 3
AU - Australia 2
BH - Bahrain 2
EG - Egitto 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.940
Città #
Ashburn 399
Singapore 330
Fairfield 252
San Jose 245
Chandler 168
Woodbridge 154
Hong Kong 146
Wilmington 132
Jacksonville 119
Ann Arbor 117
Houston 114
Seattle 100
Cambridge 81
Zgierz 80
Dublin 74
Council Bluffs 71
Frankfurt am Main 71
Moscow 68
Tokyo 67
Santa Clara 64
Medford 63
Des Moines 57
Hefei 55
Beijing 52
Nanjing 50
Palermo 46
Ho Chi Minh City 45
Kraków 40
Princeton 39
Altamura 37
Boardman 36
Los Angeles 36
Tulsa 35
Lauterbourg 31
Chicago 28
New York 28
Buffalo 27
Dearborn 25
São Paulo 23
Dallas 22
Ludwigshafen am Rhein 22
Munich 22
Hanoi 21
Lawrence 21
Kitzingen 20
Seoul 20
San Diego 19
Nanchang 17
Milan 16
Orem 16
Shenyang 16
Changsha 14
Brooklyn 13
Saint Petersburg 13
Verona 13
Brussels 12
Seongnam 12
Tianjin 12
Helsinki 11
Naples 11
Nuremberg 11
Rome 11
Guangzhou 10
London 10
Columbus 9
Da Nang 9
Denver 9
Hebei 9
San Francisco 9
Belo Horizonte 7
Bologna 7
Brasília 7
Jiaxing 7
Queens 7
Stockholm 7
Turku 7
Amsterdam 6
Istanbul 6
Rio de Janeiro 6
San Mateo 6
The Dalles 6
Auburn Hills 5
Baghdad 5
Bogotá 5
Cardiff 5
Dhaka 5
Guayaquil 5
Kunming 5
Miami 5
Montevideo 5
Montreal 5
Phoenix 5
Taizhou 5
Yerevan 5
Amman 4
Caracas 4
Chennai 4
City of London 4
Düsseldorf 4
Haiphong 4
Totale 4.203
Nome #
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 317
Founder mutations in BRCA1 and BRCA2 genes 310
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 300
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 282
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 275
Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study 235
Randomized Multicenter Phase II Trial of Two Different Schedules of Irinotecan Combined with Capecitabine as First-Line Treatment in Metastatic Colorectal Carcinoma 227
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 222
Cancer in the older person 207
Reticulocytes can represent an early indicator of erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy 204
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 201
Cancer chemotherapy in the older cancer patient 197
1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report 184
Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG) 183
Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis. 182
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O). 176
EMATOPOIESI E INVECCHIAMENTO 174
Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer A SICOG Phase II Study 168
Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial. 167
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer 166
Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings 164
Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect? 154
FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE. 151
Oncogeriatry: Communication, sharing, coordination of an emerging reality. The IIIrd Official Meeting of the AIOM Working Group on Oncogeriatry 148
Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring 147
Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC) 144
Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients 143
Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people. 142
Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer 137
Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy. 137
Sex and Gender in Ageing and Longevity: Highlights from an International Course 135
Myelotoxicity from cytostatic treatment, an important risk factor in the management of neoplasias in the elderly 135
VEGF and Chromogranin A (CgA): Possible new predictive factors in management of advanced prostatic cancer (APC) in elderly patients 131
VEGF values as a predictive factor of treatment efficiency in elderly women with advanced breast cancer 127
Safety and efficacy of two different schedules of capecitabine combined with oxaliplatin in the treatment of colon cancer in the elderly 120
Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation. 114
Non-Pegylated Liposomal Doxorubicin/Cyclophosphamide-based schedule As Antiangiogenic Treatment In Elderly Women With Advanced Breast Cancer 108
SAFETY AND EFFICACY OF INHALED IL-2 THERAPY IN PRE-TREATED BREAST CANCER ELDERLY PATIENTS WITH PULMONARY METASTASES. 107
VEGF levels could affect outcomes in elderly breast cancer women 101
Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome. 91
Totale 7.013
Categoria #
all - tutte 22.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022254 0 0 0 9 9 17 14 17 47 51 22 68
2022/2023531 71 93 0 38 86 79 45 37 51 1 24 6
2023/2024256 13 39 9 10 17 27 26 54 10 6 10 35
2024/2025626 6 34 37 75 14 25 60 52 37 60 66 160
2025/20262.393 184 78 146 151 159 328 284 239 178 510 71 65
2026/2027526 90 91 306 39 0 0 0 0 0 0 0 0
Totale 7.013